How Much Did Dash Bio Raise? Funding & Rounds and Investors

Dash Bio, officially known as Dash Bio, Inc., is a seed-stage biotechnology company founded in 2024 by Ander Tallett and Dave Johnson. Based in Boston, Massachusetts, Dash Bio operates in the biotechnology and pharmaceutical research industry. The company employs an automated clinical bioanalysis platform powered by AI and robotics, accelerating drug development by delivering high-quality assays with faster turnaround times than conventional approaches. With a team of 8 professionals, Dash Bio aims to transform the delivery of bioanalytical services for clinical trials and pharmaceutical research.

Dash Bio funding history reflects a strong commitment to innovation in biotech, having raised a total of $6.5 million in seed capital. The company has completed a single funding round as of October 2024, representing a pivotal milestone for its initial launch, expansion of operations, and rapid product development. This seed round demonstrates a strategic approach to capital, targeting investors with deep expertise in early-stage biotech and AI-driven healthcare solutions. The overall Dash Bio funding strategy is focused on building scalable, tech-enabled clinical bioanalysis capabilities that appeal to both venture capital and industry partners.

Funding Rounds

Seed - $6.5M - 2024-10-02

The $6.5 million seed funding round was raised to support Dash Bio’s initial launch and drive product development. Proceeds are being used to expand operations, further develop its automated clinical bioanalysis platform, and accelerate customer acquisition in the pharmaceutical sector.

Key Investors

Freestyle Capital

Freestyle Capital led the Dash Bio seed round, providing both funding and strategic advisory. As a top-tier venture capital firm with a focus on early-stage technology and healthcare startups, Freestyle Capital is instrumental in guiding Dash Bio’s integration of AI and automation, and in supporting its network growth within biotech and pharma.

Swift Ventures

Participating in the seed round, Swift Ventures brings deep expertise in biotech and life science investments. Swift Ventures supports Dash Bio’s go-to-market and commercialization strategies, leveraging its connections in the life sciences to foster growth and client relationships.

LifeX Ventures

LifeX Ventures also participated in Dash Bio’s seed round, complementing the investor group with a focus on life science innovation. LifeX Ventures provides resources, mentorship, and industry access, aiding Dash Bio in refining its product and accelerating its fundraising and business development efforts.

Find funding data on any company with Websets!

Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Dash Bio funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.

With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.

const run = await exa.agent.runs.create({
  query: "Research Dash Bio's funding rounds, key investors, total raised, and latest funding date. Return structured JSON with field-level citations.",
  effort: "low",
  outputSchema: {
    // company, fundingRounds, keyInvestors, totalRaised
    /* ... */
  }
});

const result = await exa.agent.runs.pollUntilFinished(run.id);

{
  "status": "completed",
  "output": {
    "structured": {
      "company": "Dash Bio",
      "fundingRounds": [
        "..."
      ],
      "keyInvestors": [
        "..."
      ],
      "totalRaised": "Dash Bio has raised a total of $6.5 million in one Seed funding round on October 2, 2024. The round was led by Freestyle Capital with participation from Swift Ventures and LifeX Ventures. The funding was aimed at expanding operations and development efforts in tech-enabled drug development services."
    },
    "grounding": [
      {
        "field": "fundingRounds[0].amount",
        "citations": [
          {
            "url": "..."
          }
        ]
      }
    ]
  }
}